General information
Lipotype GmbH
Tatzberg 47
01307 Dresden, Saxony
Germany
Contact person: Caroline Dreßler, Key Account & Business Development Manager
Company main phone: +49 (351) 2598950
Website: https://www.lipotype.com
| Year founded: | 2012
|
| Source of foundation: | Spin-off from public institution / NPO |
| Name of foundation source: | Kai Simons and Andrej Shevchenko labs of the Max-Planck-Institute of Molecular Cell Biology and Genetics |
Corporate description / mission:
Lipotype is a company providing lipidomics analysis services of various sample types including organelles, bacteria, microorganisms, cultured cells, blood plasma, tissues, organs, etc. The company offers lipids identification, comprehensive statistical analysis, and graphical presentation of data. The company uses proprietary software LipotypeXplorer that identifies lipids with the molecular fragmentation query language (MFQL).
State of ownership: Private / independent
Headquarters: HQ: Yes
Categorization
| Sector: |
- Biotechnology - R&D Services
|
| Subsector: |
- Analytical services
- CRO (Contract Research Organization)
- Screening
|
| Primary therapeutic areas: |
- Cardiovascular / cardiology
- Conditions originating in the perinatal period / pediatrics
- Digestive system / gastroenterology
- Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
- Diseases of the nervous system / neurology
- Endocrine, nutritional and metabolic diseases / endocrinology
- Genitourinary system / Urology
- Infectious and parasitic diseases / infectiology / parasitology
- Mental and behavioural disorders / psychiatry /psychology
- Musculoskeletal system and connective tissue / Orthopedics
- Neoplasms / cancer / oncology
- Pregnancy, childbirth and the puerperium / obstetrics
- Skin and subcutaneous tissue / dermatology
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
|
| Business model: |
- R&D
- Research on contract basis
- Service company
|
| Customer segments: |
- Large biotech & big pharma
- Small biotech
|